Metabolomics of the effect of AMPK activation by AICAR on human umbilical vein endothelial cells

International Journal of Molecular Medicine

Volumn 29, Issue 1, 2012, Pages 88-94

  Martínez Martín, Nuria ^a   Blas Garciá, Ana ^a,b   Morales, Jose M ^a   Marti Cabrera, Miguel ^a   Monleoń, Daniel ^c   Apostolova, Nadezda ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

AICAR; AMP activated protein kinase; Metabolic profiling; NMR spectroscopy

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ALANINE; ASPARTIC ACID; BETAINE; CHOLINE; CREATINE; CREATINE PHOSPHATE; ETHANOLAMINE; FAT DROPLET; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PHOSPHOETHANOLAMINE; SATURATED FATTY ACID;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; ENERGY CONSUMPTION; ENERGY METABOLISM; ENERGY YIELD; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIPOGENESIS; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANALYSIS OF VARIANCE; CELLS, CULTURED; CITRIC ACID CYCLE; ENZYME ACTIVATION; GLYCOLYSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHOLIPIDS; RIBONUCLEOSIDES;

EID: 84855179327     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.802     Document Type: Article

References (31)

1. Winder WW and Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277: E1-E10, 1999. (Pubitemid 29356721)
2. +-ATPase accumulation in epididymal clear cells. Am J Physiol Cell Physiol 296: C672-C681, 2009.
3. Hardie DG, Hawley SA and Scott JW: AMP-activated protein kinase: development of the energy sensor concept. J Physiol 574: 7-15, 2006. (Pubitemid 43905792)
4. Bergeron R, Ren JM, Cadman KS, et al.: Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281: E1340-E1346, 2001.
5. Viollet B, Horman S, Leclerc J, et al.: AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol 45: 276-295, 2010.
6. Lim CT, Kola B and Korbonits M: AMPK as a mediator of hormonal signalling. J Mol Endocrinol 44: 87-97, 2010.
7. Li C and Keaney JF Jr: AMP-activated protein kinase: a stress-responsive kinase with implications for cardiovascular disease. Curr Opin Pharmacol 10: 111-115, 2010.
8. Corton JM, Gillespie JG, Hawley SA and Hardie DG: 5-Aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
9. Lemieux K, Konrad D, Klip A and Marette A: The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle. FASEB J 17: 1658-1665, 2003. (Pubitemid 37100067)
10. Kim JE, Kim YW, Lee IK, Kim JY, Kang YJ and Park SY: AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D- ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression. J Pharmacol Sci 106: 394-403, 2008.
11. Li H, Thali RF, Smolak C, et al.: Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells. Am J Physiol Renal Physiol 299: F167-F177, 2010.
12. Hardie DG and Carling D: The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997. (Pubitemid 27232500)
13. Houweling M, Klein W and Geelen MJ: Regulation of phosphatidylcholine and phosphatidylethanolamine synthesis in rat hepatocytes by 5-aminoimidazole-4- carboxamide ribonucleoside (AICAR). Biochem J 362: 97-104, 2002. (Pubitemid 34174466)
14. Andrew ER and Eades RG: Removal of dipolar broadening of NMR spectra of solids by specimen rotation. Nature 183: 1802-1803, 1959.
15. Garroway AN: Magic-angle sample spinning of liquids. J Magn Reson 49: 168-171, 1982.
16. Weybright P, Millis K, Campbell N, Cory DG and Singer S: Gradient, high-resolution, magic angle spinning 1H nuclear magnetic resonance spectroscopy of intact cells. Magn Reson Med 39: 337-345, 1998.
17. Griffin JL, Bollard M, Nicholson JK and Bhakoo K: Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy. NMR Biomed 15: 375-384, 2002.
18. Monleon D, Morales JM, Gonzalez-Darder J, et al.: Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling. J Proteome Res 7: 2882-2888, 2008.
19. Xu Q and Si LY: Protective effects of AMP-activated protein kinase in the cardiovascular system. J Cell Mol Med 14: 2604-2613, 2010.
20. Jaffe EA, Nachman RL, Becker CG and Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756, 1973.
21. Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30, 2000. (Pubitemid 30047706)
22. Nicholson JK, Foxall PJ, Spraul M, Farrant RD and Lindon JC: 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 67: 793-811, 1995.
23. Barba I, Cabanas ME and Arus C: The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. Cancer Res 59: 1861-1868, 1999. (Pubitemid 29186158)
24. Nicholson JK, Lindon JC and Holmes E: 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189, 1999.
25. Menze MA, Chakraborty N, Clavenna M, et al.: Metabolic preconditioning of cells with AICAR-riboside: improved cryopreservation and cell-type specific impacts on energetics and proliferation. Cryobiology 61: 79-88, 2010.
26. Dagher Z, Ruderman N, Tornheim K and Ido Y: The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem Biophys Res Commun 265: 112-115, 1999.
27. Ojuka EO, Nolte LA and Holloszy JO: Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro. J Appl Physiol 88: 1072-1075, 2000. (Pubitemid 30154913)
28. Merrill GF, Kurth EJ, Hardie DG and Winder WW: AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273: E1107-E1112, 1997.
29. Ewart MA and Kennedy S: AMPK and vasculoprotection. Pharmacol Ther: November 25, 2010 (Epub ahead of print).
30. Hallows KR: Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism. Curr Opin Nephrol Hypertens 14: 464-471, 2005.
31. Neumann D, Schlattner U and Wallimann T: A molecular approach to the concerted action of kinases involved in energy homoeostasis. Biochem Soc Trans 31: 169-174, 2003. (Pubitemid 36241421)